Latest News

February 24, 2012
Patients with heart disease who took cholesterol-lowering statins were significantly less likely to develop depression than those who did not, in a study by Mary Whooley, MD, a physician at the San Francisco VA Medical Center and a professor of medicine at UCSF.
February 15, 2012
A UCSF stem cell study conducted in mice suggests a novel strategy for treating damaged cardiac tissue in patients following a heart attack, which an estimated 785,000 Americans will experience this year.
February 14, 2012
Peter Barnett may be the most physically active man in Mill Valley, California, thanks to UCSF's specialized cardiac care which is essential to the growing number of adults who need ongoing treatment for heart defects they've had since birth.
January 23, 2012
Scientists at the Gladstone Institutes have identified a finely tuned mechanism by which fetal heart muscle develops into a healthy and fully formed beating heart—offering new insight into the genetic causes of congenital heart disease and opening the door to one day developing therapies to fight this chronic and potentially fatal disorder.
January 19, 2012
UCSF scientists have discovered the unexpected way in which a key cell of the immune system prepares for battle. The finding, they said, offers insight into the processes that take place within these cells and could lead to strategies for treating conditions from spinal cord injury to cancer.
December 06, 2011
A UCSF study suggests patients with chronic pain may experience greater relief if their doctors add cannabinoids – the main ingredient in cannabis or medical marijuana – to an opiates-only treatment.
November 09, 2011
UCSF Medical Center performs a lower-risk cardiac procedure to treat coronary blockage that goes through the radial artery in a patient's arm, an uncommon practice in the U.S., where more than 95 percent of heart catheterizations are performed through the femoral artery in the patient’s leg.
November 04, 2011
UCSF was recently recognized as a 2011 gold-level recipient of the American Heart Association’s Start! Fit-Friendly Companies Recognition program. 
September 19, 2011
A UCSF study holds clues to why an emerging clinical trials option for heart attack patients has not been as successful as anticipated. Treatment of human hearts with bone marrow cells has led to limited to no success in improving their heart function even though a similar method has been much more effective in rodents.
September 14, 2011
High blood pressure affects 1 billion people worldwide. At least 30 percent of individual variation in blood pressure is due to genes. The largest-ever study to search for risk genes has just been published and homed in on 16 new genes. But most of the genetic contribution to blood pressure remains elusive. A new research approach may be needed.

Pages